Clinical Trials Browser

Phase 1 × relatlimab × Tumor-Agnostic × Clear all

NCT02966548 2025-02-17

Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms